“…The treatments during hospitalization were only reported in eight studies ( 15 , 18 , 20 , 22 , 23 , 34 – 36 ), which included symptomatic and supporting treatments, oral prednisone and intravenous steroids, intravenous immunoglobulin, antiviral ribavirin, and respiratory support if necessary ( Table 1 ). The follow-up durations were within hospitalization in most of the included studies, while others were with a follow-up duration of 1 month ( 36 ), 3 months ( 20 , 35 ), and 12 months ( 18 , 23 , 32 ). As for the outcomes reported, 14 studies reported the difference of LDH level at baseline between children with severe and non-severe ADVP ( 14 , 16 , 17 , 19 , 21 , 24 – 31 , 33 ), 6 studies reported the difference of LDH level at baseline between children who developed and did not develop PIBO ( 18 , 20 , 23 , 32 , 35 , 36 ), and three studies reported the association between LDH admission and in-hospital mortality of children with ADVP ( 15 , 22 , 34 ).…”